Overview
Location
United States, Florida, Miami
Employees
51-200
Founded date
2012
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 18, 2013 | New UMiami spinout applies Nobel Prize winner’s GHRH work to cancer, heart disease | GHRH antagonists are synthetic hormones intended to trigger a reduction in the hormones that fuel tumor growth. In preclinical models, Biscayne’s candidates have been “synergistic with chemotherapy” and have shown promising antitumor activi... |
| New UMiami spinout applies Nobel Prize winner’s GHRH work to cancer, heart disease | A new company spun out of the University of Miami is taking the work of a Nobel Prize-winning endocrinologist and turning it into drug candidates for treatment of cancer and heart disease. Dr. Andrew V. Schally is a pioneer in the field of ... |
Reviews 0
FAQ about Biscayne Pharma
When was Biscayne Pharma founded?
Biscayne Pharma was founded in 2012.
What has the press written about Biscayne Pharma?
Parsers VC has collected 3 articles mentioning Biscayne Pharma, among them “New UMiami spinout applies Nobel Prize winner’s GHRH work to cancer, heart disease” (Jan 18, 2013) and “New UMiami spinout applies Nobel Prize winner’s GHRH work to cancer, heart disease”.
Is Biscayne Pharma still active?
Yes, Biscayne Pharma is active; its latest activity on Parsers VC dates from Jan 30, 2017.